共 97 条
[1]
Purtilo DT(1991)Methods of detection of new families with X-linked lymphoproliferative disease Cancer Genet Cytogenet 51 143-153
[2]
Grierson HL(2000)Correlation of mutations of the SH2D1A gene and Epstein–Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease Blood 96 3118-3125
[3]
Sumegi J(1998)The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM Nature 395 462-469
[4]
Huang D(2003)Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation Nat Cell Biol 5 149-154
[5]
Lanyi A(2012)Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis Pediatr Allergy Immunol 23 488-493
[6]
Davis JD(2011)X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma Br J Haematol 152 13-30
[7]
Seemayer TA(2018)X-linked lymphoproliferative disease type 1: a clinical and molecular perspective Front Immunol 9 666-62
[8]
Maeda A(2011)X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of disease Blood 117 53-1270
[9]
Sayos J(2001)SH2D1A mutations in Japanese males with severe Epstein–Barr virus-associated illnesses Blood 98 1268-120
[10]
Wu C(2017)Maternal T and B cell engraftment in two cases of X-linked severe combined immunodeficiency with IgG gammopathy Clin Immunol 183 112-3071